BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Lim JH, Chong JU, Kim SH, Park SW, Choi JS, Lee WJ, Kim KS. Role of common bile duct resection in T2 and T3 gallbladder cancer patients. Ann Hepatobiliary Pancreat Surg. 2018;22:42-51. [PMID: 29536055 DOI: 10.14701/ahbps.2018.22.1.42] [Cited by in Crossref: 6] [Cited by in F6Publishing: 5] [Article Influence: 1.5] [Reference Citation Analysis]
Number Citing Articles
1 Fujii Y, Nanashima A, Hiyoshi M, Imamura N, Yano K, Hamada T. Significance of bile duct resection for advanced gallbladder cancer without biliary infiltration. The American Journal of Surgery 2018;216:1122-6. [DOI: 10.1016/j.amjsurg.2018.07.014] [Cited by in Crossref: 3] [Cited by in F6Publishing: 1] [Article Influence: 0.8] [Reference Citation Analysis]
2 Yu TN, Mao YY, Wei FQ, Liu H. Cystic duct cancer: Should it be deemed as a type of gallbladder cancer? World J Gastroenterol 2019; 25(44): 6541-6550 [PMID: 31802833 DOI: 10.3748/wjg.v25.i44.6541] [Cited by in CrossRef: 2] [Cited by in F6Publishing: 2] [Article Influence: 0.7] [Reference Citation Analysis]
3 Lv TR, Liu F, Hu HJ, Regmi P, Ma WJ, Yang Q, Jin YW, Li FY. The role of extra-hepatic bile duct resection in the surgical management of gallbladder carcinoma. A first meta-analysis. Eur J Surg Oncol 2021:S0748-7983(21)00940-9. [PMID: 34955314 DOI: 10.1016/j.ejso.2021.11.131] [Reference Citation Analysis]
4 Søreide K, Guest RV, Harrison EM, Kendall TJ, Garden OJ, Wigmore SJ. Systematic review of management of incidental gallbladder cancer after cholecystectomy. Br J Surg 2019;106:32-45. [PMID: 30582640 DOI: 10.1002/bjs.11035] [Cited by in Crossref: 36] [Cited by in F6Publishing: 32] [Article Influence: 12.0] [Reference Citation Analysis]
5 Sahara K, Tsilimigras DI, Maithel SK, Abbott DE, Poultsides GA, Hatzaras I, Fields RC, Weiss M, Scoggins C, Isom CA, Idrees K, Shen P, Endo I, Pawlik TM; and the US Extrahepatic Biliary Malignancy Consortium. Survival benefit of lymphadenectomy for gallbladder cancer based on the therapeutic index: An analysis of the US extrahepatic biliary malignancy consortium. J Surg Oncol 2020;121:503-10. [PMID: 31907941 DOI: 10.1002/jso.25825] [Cited by in Crossref: 8] [Cited by in F6Publishing: 3] [Article Influence: 4.0] [Reference Citation Analysis]
6 Matsukuma S, Tokumitsu Y, Shindo Y, Matsui H, Nagano H. Essential updates to the surgical treatment of biliary tract cancer. Ann Gastroenterol Surg 2019;3:378-89. [PMID: 31346577 DOI: 10.1002/ags3.12266] [Cited by in Crossref: 13] [Cited by in F6Publishing: 13] [Article Influence: 4.3] [Reference Citation Analysis]